← Eichor
Study identifier: NCT06512259 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

Condition: Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy  ·  Sponsor: AlloSource

PhaseN/A
Planned participants200
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a single-center, retrospective study which will be used to describe and evaluate the effectiveness of AlloMend® Acellular Dermal Matrix allograft for patients that have undergone Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.

This description comes directly from the study's public registry record.

Talk to the study team

Elizabeth Esterl, DNP, MS, RN  ·  7207326231  ·  eesterl@allosource.org

Paige McHenry, MS, ATC, CCRA  ·  2154997062  ·  pmchenry@allosource.org

Always discuss trial participation with your own doctor first.

Locations (1)

Alan H. Chen Surgical Associates, PCJoliet, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06512259